Summation Bio, Inc.Summation Bio, Inc.
SB

Summation Bio, Inc.

Biotechnology company

2021Inactive

About

Summation Bio, Inc. is a biotechnology company dedicated to advancing the treatment of complex diseases. They leverage cutting-edge scientific approaches to discover and develop innovative therapeutic candidates, aiming to address unmet medical needs.

Technology stack

detected 2026-05-23
Est. monthly stack spend~$70/mo
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Summation Bio, Inc. do?

Summation Bio, Inc. is a biotechnology company dedicated to advancing the treatment of complex diseases. They leverage cutting-edge scientific approaches to discover and develop innovative therapeutic candidates, aiming to address unmet medical needs.

How much funding has Summation Bio, Inc. raised?

Summation Bio, Inc. has raised a total of $10M in funding. The most recent round on record is Seed.

Where is Summation Bio, Inc. headquartered?

Summation Bio, Inc. is headquartered in Cambridge, United States.

When was Summation Bio, Inc. founded?

Summation Bio, Inc. was founded in 2021.

What industry does Summation Bio, Inc. operate in?

Summation Bio, Inc. operates in Biotech, Drug Discovery, Genomics, HealthTech, AI-Driven Protein Design.

What is Summation Bio, Inc.'s current status?

Summation Bio, Inc.'s current operating status is: Inactive.